Intelligent Bio Solutions Inc 's Cash & cash equivalent grew by 43.18 % in the Q1 2026 sequentially, while Current Liabilities decreased, this led to improvement in Intelligent Bio Solutions Inc 's Quick Ratio to 1.3, Quick Ratio remained below Intelligent Bio Solutions Inc average.

Within Medical Equipment & Supplies industry 115 other companies have achieved higher Quick Ratio than Intelligent Bio Solutions Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 1333 to 1960.

Explain Quick Ratio?
How much Cash & cash equivalents INBS�s has?
What are INBS�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/INBS/financial-strength

https://api.csimarket.com/api/v1/companies/INBS/fundamentals

https://api.csimarket.com/api/v1/companies/INBS/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

INBS Quick Ratio	(Sep 30 2026) Q1	(Jun 30 2026) Q4	(Mar 31 2026) Q3	(Dec 31 2025) Q2	(Sep 30 2025) Q1
Y / Y Current Liabilities Change	-9.55 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	257.2 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	1.3	Subscribe	Subscribe	Subscribe	Subscribe
INBS's Total Ranking	# 1960	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-7.23 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	43.18 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio first quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 116
Healthcare Sector	# 658
Overall Market	# 1960

Quick Ratio Statistics
High	Average	Low
13.36	1.86	0.03
(Dec 31 2020)		(Sep 30 2023)

Financial Statements
Intelligent Bio Solutions Inc 's Current Liabilities	$ 5 Millions	Visit INBS's Balance sheet
Intelligent Bio Solutions Inc 's Cash & cash equivalent	$ 6 Millions	Visit INBS's Balance sheet
Source of INBS's Sales		Visit INBS's Sales by Geography

Cumulative Intelligent Bio Solutions Inc 's Quick Ratio

INBS's Quick Ratio for the trailling 12 Months

INBS Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-4.66 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	52.26 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.92	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4040	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-2.42 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	31.2 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to INBS Financial Strength Comparisons >> Go to Compare INBS Quick Ratio to its Competitors

On the trailing twelve months basis INBS Cash & cash equivalent more than doubled by 257.2 % in Q1 2026 year on year, while Current Liabilities decreased to $5 millions, this led to increase in in Intelligent Bio Solutions Inc 's Quick Ratio to 0.92, Quick Ratio remained below INBS average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 203 other companies have achieved higher Quick Ratio than Intelligent Bio Solutions Inc . While Quick Ratio overall ranking has improved so far to 4040, from total ranking during the twelve months ending fourth quarter 2026 at 4051.

Explain Quick Ratio?
How much Cash & cash equivalents INBS�s has?
What are INBS�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 204
Healthcare Sector	# 901
Within the Market	# 4040

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.69	1.02	0.24
(Jun 30 2022)		(Dec 31 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Capsovision Inc	3.55	$ 21.757 Millions	$ 6.124 Millions
Profound Medical Corp	3.41	$ 33.343 Millions	$ 9.771 Millions
Rxsight Inc	3.40	$ 254.683 Millions	$ 74.952 Millions
Omada Health Inc	3.23	$ 243.151 Millions	$ 75.379 Millions
Transmedics Group Inc	3.22	$ 492.962 Millions	$ 152.857 Millions
Trisalus Life Sciences Inc	3.15	$ 41.057 Millions	$ 13.014 Millions
Procept Biorobotics Corporation	3.10	$ 218.369 Millions	$ 70.353 Millions
Carlsmed Inc	3.08	$ 56.207 Millions	$ 18.237 Millions
Neuropace Inc	3.08	$ 49.431 Millions	$ 16.070 Millions
Outset Medical Inc	3.07	$ 136.627 Millions	$ 44.453 Millions
Sharps Technology Inc	2.82	$ 7.478 Millions	$ 2.650 Millions
Edwards Lifesciences Corporation	2.81	$ 4,683.700 Millions	$ 1,664.300 Millions
Mimedx Group Inc	2.81	$ 120.791 Millions	$ 43.031 Millions
Streamex Corp	2.80	$ 26.248 Millions	$ 9.382 Millions
Pulse Biosciences Inc	2.74	$ 36.725 Millions	$ 13.395 Millions
Staar Surgical Co	2.73	$ 206.414 Millions	$ 75.541 Millions
Medinotec Inc	2.68	$ 2.584 Millions	$ 0.963 Millions
Glaukos Corp	2.66	$ 337.478 Millions	$ 126.726 Millions
Pulmonx Corporation	2.57	$ 53.245 Millions	$ 20.739 Millions
Beta Bionics Inc	2.48	$ 81.551 Millions	$ 32.836 Millions
Irhythm Holdings Inc	2.46	$ 560.719 Millions	$ 228.025 Millions
Genedx Holdings Corp	2.38	$ 170.118 Millions	$ 71.403 Millions
Apyx Medical Corp	2.37	$ 25.777 Millions	$ 10.870 Millions
Atricure Inc	2.23	$ 187.031 Millions	$ 83.972 Millions
Vivani Medical Inc	2.22	$ 14.591 Millions	$ 6.585 Millions
Electromed Inc	2.19	$ 15.875 Millions	$ 7.261 Millions
Inspire Medical Systems inc	1.96	$ 190.803 Millions	$ 97.438 Millions
Aethlon Medical Inc	1.91	$ 6.487 Millions	$ 3.403 Millions
Merit Medical Systems Inc	1.90	$ 503.551 Millions	$ 265.083 Millions
Nephros Inc	1.89	$ 4.546 Millions	$ 2.409 Millions

Date modified: 2026-11-11T18:29:47+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.